Pactiv Evergreen Inc.(PTVE) Stock Research - Grey Stern Research

Pactiv Evergreen Inc. (PTVE) Stock Analysis

$13.11 (2.82%)

PTVE Financial Performance


Use the table below to view Pactiv Evergreen Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q1 - 2024

Metric Value Ranking among Peers
Price $13.11 -
52 Week Low $7.41 -
52 Week High $15.84 -
Market Cap $2.3 Billion 3/5
Gross Margin 19% 4/5
Profit Margin 2% 3/5
EBITDA margin 6% 4/5
Q1 - 2024 Revenue $1.2 Billion 1/5
Q1 - 2024 Earnings $20.0 Million 3/5
Q1 - 2024 Free Cash Flow -$74.0 Million 5/5
Trailing 4 Quarters Revenue $5.2 Billion 1/5
Trailing 4 Quarters Earnings -$26.0 Million 4/5
Quarterly Earnings Growth 115% 2/5
Annual Earnings Growth 53% 2/5
Quarterly Revenue Growth -18% 5/5
Annual Revenue Growth -12% 5/5
Cash On Hand $71.0 Million 3/5
Short Term Debt $91.0 Million 1/5
Long Term Debt $3.6 Billion 1/5

Pactiv Evergreen Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Pactiv Evergreen Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE -1.00 4/5
PS 0.46 5/5
PB 1.74 3/5
PC 33.08 3/5
Liabilities to Equity 3.75 2/5
ROA 0.00 3/5
ROE -0.02 4/5
Current Ratio 1.27 5/5
Quick Ratio 0.01 5/5
Long Term Debt to Equity 2.65 1/5
Debt to Equity 2.90 1/5
Burn Rate 0.49 3/5
Cash to Cap 0.03 2/5
CCR -3.70 5/5
EV to EBITDA 83.36 2/5
EV to Revenue 1.20 5/5

Company Details

Pactiv Evergreen Inc. manufactures and distributes fresh foodservice and food merchandising products, and fresh beverage cartons in North America. It operates through three segments: Foodservice, Food Merchandising, and Beverage Merchandising. The Foodservice segment offers food containers, hot and cold cups, lids, dinnerware, tableware, service ware, and other products. The Food Merchandising segment provides clear rigid-display containers, containers for prepared and ready-to-eat food, trays for meat and poultry, and molded fiber cartons. The Beverage Merchandising segment offers cartons for fresh refrigerated beverage products. This segment also provides integrated fresh carton systems, which include printed cartons with high-impact graphics, spouts, and filling machines, as well as fiber-based liquid packaging board and range of paper-based products. The company serves full-service restaurants, quick service restaurants, foodservice distributors, supermarkets, grocery and healthy eating retailers, other food stores, food and beverage producers, and food packers and food processors. The company was formerly known as Reynolds Group Holdings Limited. Pactiv Evergreen Inc. was founded in 1880 and is headquartered in Lake Forest, Illinois. Pactiv Evergreen Inc. is a subsidiary of Packaging Finance Limited.

CEO: Mr. Thomas James Degnan BA

Website: https://www.pactivevergreen.com

Address: 1900 West Field Court Lake Forest, IL

Exchange: NASDAQ Global Select

Industry: Packaging & Containers

Pactiv Evergreen Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Pactiv Evergreen Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Reynolds Consumer Products Inc. REYN $5.8 Billion
Vitru Limited VTRU $304.2 Million
StepStone Group Inc. STEP $5.6 Billion
PMV Pharmaceuticals, Inc. PMVP $86.9 Million
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
PTVE Income Statements
Quarter Year Revenue Earnings
Q1 2024 $ 1.2 Billion $20.0 Million
Q4 2023 $ 1.2 Billion $21.0 Million
Q3 2023 $ 1.4 Billion $72.0 Million
Q2 2023 $ 1.4 Billion -$139.0 Million
Q1 2023 $ 1.4 Billion -$133.0 Million
Q4 2022 $ 1.5 Billion $26.0 Million
Q3 2022 $ 1.6 Billion $176.0 Million
Q2 2022 $ 1.6 Billion $73.0 Million

View All

PTVE Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q1 2024 $71.0 Million $6.4 Billion $3.9 Billion $1.3 Billion
Q4 2023 $164.0 Million $6.4 Billion $3.9 Billion $1.3 Billion
Q3 2023 $233.0 Million $6.4 Billion $4.0 Billion $1.3 Billion
Q2 2023 $302.0 Million $6.6 Billion $4.1 Billion $1.3 Billion
Q1 2023 $427.0 Million $7.0 Billion $4.3 Billion $1.4 Billion
Q4 2022 $531.0 Million $7.3 Billion $4.4 Billion $1.5 Billion
Q3 2022 $559.0 Million $7.4 Billion $4.6 Billion $1.5 Billion
Q2 2022 $246.0 Million $7.3 Billion $4.7 Billion $1.3 Billion

View All

PTVE Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q1 2024 -$74.0 Million -$41.0 Million -$93.0 Million
Q4 2023 $81.0 Million $0 -$70.0 Million
Q3 2023 $0 $0 $0
Q2 2023 $74.0 Million -$53.0 Million -$125.0 Million
Q1 2023 $25.0 Million -$63.0 Million -$106.0 Million
Q4 2022 $84.0 Million -$89.0 Million -$33.0 Million
Q3 2022 $20.0 Million -$55.0 Million $311.0 Million
Q2 2022 $52.0 Million -$114.0 Million $41.0 Million

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions